Nahdi Medical Company
Saudi Stock Exchange 4164.SR
Nahdi Medical Company Shareholders' Equity for the year ending December 31, 2023: USD 655.73 M
-
Nahdi Medical Company Shareholders' Equity for the year ending December 31, 2022 was USD 596.02 M, a 39.74% change year over year.
-
Nahdi Medical Company Shareholders' Equity for the year ending December 31, 2021 was USD 426.52 M, a -22.91% change year over year.
-
Nahdi Medical Company Shareholders' Equity for the year ending December 31, 2020 was USD 553.25 M, a 16.48% change year over year.
-
Nahdi Medical Company Shareholders' Equity for the year ending December 31, 2019 was USD 474.95 M, a 6.28% change year over year.
| Date | Shareholders' Equity | Minority Interest | Total Equity | Total Stockholders Equity and Liabilities |
|---|
| CEO | Mr. Yasser Ghulam Bin Abdulaziz Joharji |
| IPO Date | April 18, 2022 |
| Location | Saudi Arabia |
| Headquarters | Abraq Al-Roghamah District |
| Employees | 5,169 |
| Sector | Health Care |
| Industries | |
Nahdi Medical Company operates as a pharmaceutical retailer in the Kingdom of Saudi Arabia and the United Arab Emirates. The company offers pharmaceutical and health products, such as medicine, wellness, mom and baby, beauty, and other FMCG products. It also provides omni-health services through its polyclinics, express clinics, telemedicine, labs, and home healthcare. In addition, the company engages in the wholesale and retail trading of cosmetics, pharmaceutical products, special and healthy foods, and medical equipment. It operates approximately 1,151 pharmacies. The company was founded in 1986 and is headquartered in Jeddah, the Kingdom of Saudi Arabia. Nahdi Medical Company operates as a subsidiary of Alnahdi Holding Company Limited and Saudi Economic and Development Company Limited.
Past 5 years
USD 20.64
USD 313.79
USD 17.42
USD 78.21
USD 106.72
StockViz Staff
January 16, 2025
Any question? Send us an email